Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Donna Catamero"'
Autor:
Seunghee Kim-Schulze, Sundar Jagannath, Sacha Gnjatic, Ajai Chari, Samir Parekh, Keren Osman, Selma Bekri, Hearn Jay Cho, David G Coffey, Adolfo Aleman, Simone Kats, Amishi Dhadwal, Donna Catamero
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background Autologous stem cell transplantation (ASCT) after induction therapy improves disease-free survival for patients with multiple myeloma (MM). While the goal of ASCT is to render a minimal disease state, it is also associated with eradication
Externí odkaz:
https://doaj.org/article/4790a00a661e458ba2ebf32b8bdaa81f
Autor:
Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood Advances, Vol 1, Iss 19, Pp 1575-1583 (2017)
Abstract: Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when combined with immunomodulatory drugs. This study is a single-center phase 2 study of pa
Externí odkaz:
https://doaj.org/article/c6d9e6ac5c2e415ea1de9942843d0af4
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 14:252-256
Therapeutic options for patients with multiple myeloma have multiplied in the past decade. However, multiple myeloma remains an incurable disease, and relapsed/refractory myeloma is characterized by genetic and cytogenetic alterations that drive resi
Autor:
Donna Catamero, ANP-BC, OCN, CCRC, Tiffany Richards, PhD, ANP-BC, AOCNP, Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN
Publikováno v:
Journal of the advanced practitioner in oncology. 13(Suppl 4)
Significant strides have been made in the management of patients living with myeloma. However, patients with multiply relapsed or refractory multiple myeloma (MM) have a shorter overall survival; therefore, new treatments with novel mechanisms of act
Autor:
Donna Catamero, Cesar Rodriguez, Amishi Dhadwal, Brian Kunzel, Joshua Richter, Ajai Chari, Sundar Jagannath
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S196-S197
Autor:
Debra Wujcik, Sandra E. Kurtin, Agnes Davis, Tanya M. Wildes, Carrie Tompkins Stricker, William N. Dudley, Kristy Birchard, Nitya Nathwani, Supriya G. Mohile, Donna Catamero, Brea Lipe
Publikováno v:
JCO Oncology Practice. 16:e92-e99
PURPOSE: Geriatric assessment (GA) results predict toxicity/survival in older adults, yet GA is not routinely used in care for patients with multiple myeloma (MM). We tested a tablet-based modified GA (mGA) providing real-time results to clinicians.
Publikováno v:
Journal of the Advanced Practitioner in Oncology
With conference reporting provided by The ASCO Post, Amber B. Koehler, PA-C, MS, of Mayo Clinic, evaluates data on BTK inhibitors; fixed-duration, first-line treatment with ibrutinib plus venetoclax; and a novel oral BCL2 antagonist for patients with
Autor:
Elizabeth Aronson, Kiah Purcell, Annel Aponte, Karen Louw, Donna Catamero, Angela Lamb, Diana Kirke, Aimee Lucas, Sundar Jagannath, Ajai Chari
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S195
Autor:
Amit Agarwal, Mohit Narang, Mazaher Dhalla, James L. Omel, Sikander Ailawadhi, Donna Catamero, Kathleen Toomey, Robert M. Rifkin, Howard R. Terebelo, Amani Kitali, James W. Hardin, Shankar Srinivasan, Sundar Jagannath, Brian G.M. Durie, Rafat Abonour, Cristina Gasparetto, Lynne I. Wagner
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(3)
Background The t (11;14) (q13;32) translocation [t (11;14)] is present in ∼20% of patients with newly diagnosed multiple myeloma (NDMM), but studies examining its prognostic ability have yielded divergent results, and data are lacking on outcomes f
Autor:
Amit Verma, Murali Janakiram, Gurbakhash Kaur, Joshua Heisler, Tonya Aaron, Donna Catamero, Ira Braunschweig, Mateo Mejia Saldarriaga, R. Alejandro Sica, Natasha Ghalib, Noah Kornblum, Lizamarie Bachier, Lihua Yue, Nishi Shah, Nadia Ashai, Daniel Cole, Ioannis Mantzaris, Zhengrui Xiao, Olga Derman, Sanjay Goel, Niyati Goradia, Aditi Shastri, Rebecca Foreman
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(4)
Multiple myeloma (MM) in Hispanics has never been studied. We therefore sought to determine the clinical characteristics and overall survival in MM of Hispanics compared to non-Hispanic whites (NHW) and non-Hispanic blacks (NHB).A single-center analy